To be able to detect in situ changes in protein conformation without perturbing the physiological environment would be a major step forward in understanding the precise mechanism occurring in protein interaction. We have developed a novel approach to monitoring conformational changes of proteins in intact cells. A double-labelled fluorescent green fluorescent protein-yellow fluorescent protein (GFP-YFP) fusion protein has been constructed, allowing the exploitation of enhanced-acceptorfluorescence (EAF)-induced fluorescence resonance energy transfer (FRET). Additionally, a novel fusion partner, YFP dark , has been designed to act as a sterically hindered control for EAF-FRET. Any conformational changes will cause a variation in FRET, which, in turn, is detected by fluorescence lifetime imaging microscopy ('FLIM'). Protein kinase B (PKB)/Akt, a key component of phosphoinositide 3-kinase-mediated signalling, was selected for this purpose. Although conformational changes in PKB/Akt consequent to lipid binding and phosphorylation have been proposed in models, its behaviour in intact cells has not been tractable. We report here that platelet-derived-growthfactor ('PDGF') stimulation of NIH3T3 cells expressing the GFPAkt-YFP construct resulted in a loss of FRET at the plasma membrane and hence a change in PKB/Akt conformation. We also show that the GFP-Akt-YFP construct conserves fully its functional integrity. This novel approach of monitoring the in situ conformational changes has broad application for other members of the AGC kinase superfamily and other proteins.
INTRODUCTION
The ability to detect in situ changes in protein conformation without perturbing the cellular environment would give new insight into the precise mechanisms occurring in protein interactions. For this purpose, we have selected protein kinase B (PKB)/Akt, a member of the AGC kinase superfamily, which plays an important role in phosphoinositide 3-kinase-mediated cellular signalling such as cell survival and growth [1] .
In order to investigate intramolecular conformational changes of PKB/Akt, we introduced two different fluorophores, green fluorescent protein (GFP) and yellow fluorescent protein (YFP) respectively, on either end of PKB/Akt to create a double fluorescent-tagged construct, GFP-Akt-YFP. Fluorescence resonance energy transfer (FRET) between spectrally similar GFP molecules in single cells has been demonstrated previously [2] . FRET induced by enhanced acceptor fluorescence (EAF) results in the increase of the combined fluorescence lifetime of both donor and acceptor. To control for EAF induced FRET we have used a new dark YFP (YFP dark ) fused to make the GFP-Akt-YFP dark construct, which allows verification of these types of measurements using the full-length protein. This variation in FRET is measured by fluorescence lifetime imaging microscopy (FLIM) and is thus independent of local concentration variations [3, 4] .
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The activation of PKB/Akt and its subsequent translocation to the membrane is dependent on the integrity of its N-terminal pleckstrin homology (PH) domain, which binds to the phosphoinositide 3-kinase-generated second messengers PtdIns(3,4,5)P 3 and PtdIns(3,4)P 2 [5] . In addition, PKB/Akt is subject to regulation by phosphorylation, a feature shared with most members of the AGC superfamily growth [1, 6] . Two important regulatory sites for full Akt activation have been identified so far: Thr 308 in the kinase domain and Ser 473 in the hydrophobic motif of the C-terminal part [7] . Recent crystalstructure studies [8, 9] indicated that conformational changes within PKB/Akt regulate its lipid binding and activity [1] .
In the present study we show that the change in the intramolecular proximity of GFP and YFP causes a variation in FRET coupling efficiency, which is, in turn, imaged in cells using FLIM. Thus, for the first time, using this particular methodology, conformational change of a full-length protein kinase in response to a growth factor can be monitored in situ.
EXPERIMENTAL

DNA constructs and expression vectors
The pEGFP-C1-GFP-Akt fusion construct, where GFP is fused in N-terminus of haemagglutinin A-tagged mouse Akt1, was made as previously described [10] . The YFP-Akt construct was made by cutting out YFP from pEYFP-N1 (Clontech) using restriction endonucleases NheI/BsrGI and was placed instead of the enhanced GFP (EGFP) in the pEGFP-C1-GFP-Akt construct in the NheI/BsrGI sites. GFP-Akt from pEGFP-C1-GFP-Akt was PCR-amplified using the sense oligonucleotide 5 -AGAGGATCCGCCGCCACCATGGTGAGCAAGGGCGAGG-AGCTGTTCACCGGG-3 and the antisense oligonucleotide 5 -ATCGAATTCTCCGCCACCTCCACCTCCGGTGTGCCAC-TGGCTGAGTAGGAGAACTGGGG-3 , cut with BamHI/ EcoRI and introduced as an N-terminal fusion in a pCDNA3 vector containing enhanced YFP (EYFP; kindly provided by Dr Thomas Gudermann, Institut für Pharmakologie und Toxikologie, Philipps Universität Marburg, Marburg, Germany [11] ) in BamHI/EcoRI sites to make the GFP-Akt-YFP construct. A linker formed of six glycine residues separates N-terminal EGFP from Akt and C-terminal EYFP from Akt in GFP-Akt-YFP. An environmentally stable (red-shifted) form of EYFP [12] was made by replacing the glutamine residue at position 70 of EYFP by a methionine residue. Site-directed mutagenesis was performed by using the QuikChange mutagenesis kit (Stratagene). All the constructs described above were made with the Gln 70 → Met mutation on EYFP. EYFP dark was made by replacing Tyr 67 in the EYFP chromophore with a leucine residue. This mutation quenches the fluorescence emission of EYFP.
Immunoprecipitation and in vitro GFP-Akt-YFP kinase assay NIH3T3 cells seeded at 140 000 cells/six-well plate were transfected with the GFP-Akt-YFP construct using LIPOFECTAMINE/PLUS TM reagent (Gibco BRL) and starved in Dulbecco's modified Eagle's medium/0.2 % BSA. After treatment, the cells were lysed for 15 min on ice in lysis buffer [20 mM Tris/HCl (pH 7.4)/150 mM NaCl/100 mM NaF/10 mM Na 4 P 2 O 7 /10 mM EDTA, supplemented with 1 mM Na 3 VO 4 , 1 mM PMSF, 10 µg/ml leupeptin and 10 µg/ml aprotinin]. GFP-Akt-YFP was immunoprecipitated with high-affinity rat monoclonal anti-(haemagglutinin A) antibody (Boehringer-Mannheim) for 2 h at 4
• C on Protein G-Sepharose beads. Immunoprecipitates of GFP-Akt-YFP were washed twice with the lysis buffer and twice with the kinase buffer (1×) [25 mM Tris/HCl (pH 7.5)/5 mM β-glycerophosphate/2 mM dithiothreitol/0.1 mM Na 3 VO 4 /10 mM 
Western-blot analysis
The gels were transferred to PVDF membrane (Immobilon P; Millipore) and incubated in blocking buffer TBS-T [10 mM Tris/HCl (pH 7.4)/150 mM NaCl/0.05 % Tween-20], supplemented with 3 % BSA for 1 h. The membrane was washed in TBS/Triton/1 % milk for 1 h and incubated with the different antibodies; phospho-Akt (Thr 308 ) or phospho-GSK3α,β (Ser 21/9 )
antibodies (rabbit polyclonal antibody from Cell Signaling) or phospho-Akt (Ser 473 ) (rabbit polyclonal antibody raised against the C-terminal phosphopeptide HFPQFpSYSASS of Akt1) at 1:1000 dilution for 2-3 h in TBS/Triton/3 % BSA. Anti-GFP (mouse monoclonal antibody; CRUK Immunology Group, Paterson Institute for Cancer Research, Christie Hospital, Manchester, U.K.) was used at 1:10 000 dilution for 30 min. The secondary horseradish-peroxidase-conjugated antibodies were used at 1:5000 dilution and proteins revealed by enhanced chemiluminescence (ECL R ; Amersham Biosciences).
Confocal microscopy
NIH3T3 cells were seeded at 30 000 cells/well on glass coverslips in 24-well plates and transfected as described above. After treatment the cells were washed twice in PBS and fixed in 4 % paraformaldehyde for 15 min. The coverslips were washed and mounted on the slides with Immuno Floure (ICN Biomedicals, Costa Mesa, CA, U.S.A.). The slides were then analysed by confocal microscopy using a Zeiss laser scanning confocal microscope (LSM 510), an Argon 458/488 laser and a 63× Apochromat oil-immersion objective lens.
Measurement of FRET by FLIM in the frequency domain
A detailed description of the FRET monitored by FLIM can be found elsewhere [3] . We have monitored lifetime detection in the frequency (phase) domain. Phase methods provide an average lifetime where sinusoidally modulated light is used to excite the sample. The lag in the emitted fluorescence signal permits measurement of phase (τ p ) and modulation depth (τ m ) of the fluorescence. The lifetime, τ , is the average of phase shift and relative modulation depth (τ m + τ p )/2 of the emitted fluorescence signal. In this particular study, since GFP and YFP are spectrally similar EAF occurs, which, in turn, induces FRET, we monitor the variation in the combined change in lifetime of donor (GFP) and acceptor (red-shifted YFP). The detailed explanation of EAF and its effect on FRET efficiency can be found elsewhere [2, 13] . It is noteworthy that, in the present study, FRET is detected when there is an increase in the combined donor and acceptor lifetime, and the absence of FRET is detected by the decrease in lifetime to the uncomplexed donor lifetime. GraphPad InStat software (version 3.0 for Mac-2001) was used for the statistical analysis. An unpaired t test with Welch correction was used to determine the significance of variation in lifetime between GFPAkt, GFP-Akt-YFP and Akt-YFP (seven or more cells were analysed per experiment; n = 4). The P values were determined at 95 % confidence interval.
All images were taken using a Zeiss Plan-Apochromat 100×/1.4-numerical-aperture phase-3 oil-immersion objective, with images recorded at a modulation frequency of 80.218 MHz. The GFP-Akt-YFP was excited using the 488 nm line of an argon/krypton laser and the resultant fluorescence separated using a combination of dichroic beam splitter (Q 505 LP; Chroma Technology Corp., Brattleboro, VT, U.S.A.) and interference filter (HQ510/20; Chroma Technology Corp.)
Time domain
Time-correlated single-photon-counting FLIM was performed using a modified multi-photon microscope system [Bio-Rad MRC 1024MP and Becker & Hickl GmbH (Berlin, Germany) SPC700] described previously [14] photons · s −1 , below the maximum counting rate afforded by the TCSPC (time-correlated single-photon counting) card to avoid pulse pile-up. Samples were imaged for ≈ 120 s to achieve appropriate photon statistics for determination of the fluorescence dynamics. Data was analysed using in-house-developed software tools.
RESULTS
To study intramolecular conformational changes of a full-length protein in intact cells we constructed a double-tagged Akt construct with spectrally similar fluorophores: GFP at the Nterminus and YFP at the C-terminus. Primarily, we wanted to verify whether the GFP-Akt-YFP construct resulted in EAFinduced FRET and also to confirm that variations of lifetime were not due to the multiple decay components of the GFP-Akt-YFP. The appropriate control for the latter was the construction of a YFP the fluorescence emission of which is quenched (YFP dark ). YFP dark has Tyr 67 mutated to leucine. The advantage of using the 'dark' YFP as a control is that it maintains the overall structure of the chimaeric sensor protein.
We show that, in the presence of the YFP dark (GFP-Akt-YFP dark ), the lifetime decreases to that of GFP alone, confirming that YFP acts as a proper acceptor in the GFP-Akt-YFP construct. Furthermore, this demonstrates that the quenching of the GFP was not due to its local environment. This decrease is detected in the average lifetime ( Figure 1A ) and in the two-dimensional histogram, where the blue dot (GFP-Akt-YFP dark ) and green dot (GFP-Akt) superimpose and is clearly distinct from that of GFP-Akt-YFP (red; Figure 1B ). Confirmation that FRET occurs between GFP and redshifted YFP allowed us to examine whether Akt undergoes conformation changes upon stimulation with platelet-derived growth factor (PDGF). We monitored variation in lifetime of GFP-Akt-YFP in intact cells by FLIM. NIH3T3 cells were transiently transfected with GFP-Akt, GFP-Akt-YFP and YFPAkt fluorescent constructs. The intensity images are shown in the upper panel of Figure 2 (A). It must be noted that loss of resolution in the intensity images is due the intrinsic properties of the detector (an image intensifier) used for frequency domain FLIM and the image treatment required for the measurement of lifetime. The images were thresholded in such a manner that the signalto-noise ratio was systematically 2:1 and therefore the plasma membrane was not eliminated. The lifetime distribution in each case was determined (Figure 2A, lower panel) . The average lifetimes are 2.14 + − 0.03 ns, 2.33 + − 0.02 ns and 2.41 + − 0.01 ns for GFP-Akt, GFP-Akt-YFP and YFP-Akt respectively ( Figure 2C ). The cells transfected with GFP-Akt-YFP undergo FRET induced by EAF. That is, the two fluorophores are in close proximity (< 7 nm) for resonance energy transfer to occur. The two-dimensional histogram illustrates a concomitant increase (upward diagonal shift) in the combined lifetime of GFP-Akt-YFP compared with GFP-Akt ( Figure 2B ). However, when the GFP-Akt-YFP-transfected cells were treated for 5 min with 30 ng/ml PDGF, a decrease in the lifetime at the plasma membrane from 2.3 ns to 1.7 ns is detected (Figure 2A ). The selected lifetime regions of interest further demonstrate this change. The pixels with low lifetime distribution (white, 1.7-2.0 ns) are at the plasma membrane and the pixels with higher lifetime distribution (blue, 2.0-2.5 ns) are in the cytoplasm (Figure 2A , right-hand bottom panels). The loss of energy transfer reflects a separation between the fluorophores and hence a change in Akt conformation. The conformation that results in FRET is referred to as the 'closed' conformation and that with the loss of FRET the 'open' conformation of Akt ( Figure 2D ).
To confirm the functional integrity of the GFP-Akt-YFP construct, we verified by confocal microscopy that single-tagged GFP-Akt and YFP-Akt as well as GFP-Akt-YFP translocated to the plasma membrane upon PDGF stimulation. This is apparent in the lower panel of Figure 3(A) . Moreover, we have demonstrated that Thr 308 and Ser 473 are both phosphorylated and the downstream target (GSK3) is also phosphorylated (Figures 3B and  3C) . Notably there was no steric hindrance of YFP on Ser 473 site phosphorylation, since PDGF induced phosphorylation, as did inhibition of protein phosphatase 1/protein phosphatase 2A with okadaic acid ( Figure 3C ).
To further demonstrate the physiological relevance of the Akt conformational change detected by the decrease of GFP-Akt-YFP lifetime at the plasma membrane, we treated cells with LY294002 (an inhibitor of phosphoinositide 3-kinase). Figure 4(A) shows that, upon PDGF stimulation, there is a loss of FRET ('open' conformation) at the plasma membrane, indicated by the decrease in the GFP-Akt-YFP lifetime from 2.3 to 1.7 ns. In the presence of LY294002, this phenomenon is partially prevented (lifetime at the plasma membrane remains unchanged). Concomitantly, upon LY294002 pretreatment, we observed a decrease in the PDGF-induced GFP-Akt-YFP phosphorylation on Thr 308 ( Figure 4B , upper panel). In the same manner, a decrease in phosphorylation occurs with the endogenous protein ( Figure 4B , lower panel).
DISCUSSION
Our interest has been focused on developing a novel way for monitoring in situ the change in conformation of a full-length protein. For this purpose we utilized a protein of interest, namely The transfer of energy between the GFP donor and redshifted YFP acceptor within the GFP-Akt-YFP construct was measured under non-stimulated conditions. However, a loss of the FRET was monitored after PDGF stimulation at the plasma membrane. Therefore we conclude that the loss of the energy transfer was due to a change in the conformation of Akt from a 'closed' conformation (occurrence of FRET) in the basal condition to an 'open' conformation (loss of FRET) on PDGF treatment.
The activation of Akt after growth-factor stimulation has been shown to be strictly dependent on its translocation to the plasma membrane and on the phosphorylation of its regulatory sites Thr 308 and Ser 473 (on Akt1) by upstream kinase(s) [15, 16] . The translocation of Akt was dependent on the integrity of its PH domain, which interacts with the lipid products of the phosphoinositide 3-kinase pathway. However, in vitro, an increase in the activity of Akt has been measured when the PH domain was deleted (' PH-Akt') [17] , implying that the PH domain negatively regulates the basal Akt kinase activity. A hypothesis to explain the dual role of the PH domain was that, in vivo, its association with the 3 -phosphoinositides after translocation at the plasma membrane upon activation induced an Akt conformational change that would release its inhibitory action. This conformational change could be stabilised by subsequent phosphorylation of Akt by upstream kinases, or could act to promote such phosphorylation. These latter issues will be the subject of future studies using the GFP-Akt-YFP construct. Recently, the crystal structure of the Akt kinase domain has been published and a mechanism for Akt activation involving a change in conformation of the hydrophobic C-terminal motif dependent on Thr 308 and Ser 473 phophorylations demonstrated [9] . However, in the crystallisation studies the suggested role of the PH domain in a conformational change of Akt, referred to above, could not be assessed, because the Akt PH domain had to be deleted for the purposes of crystallisation.
We demonstrate that this change in Akt conformation upon PDGF stimulation is dependent on the production of the 3 -phosphoinositide products of phosphoinositide 3-kinase, since it is largely prevented by treatment with an inhibitor of phosphoinositide 3-kinase, which also decreased the translocation of Akt to the plasma membrane. We have illustrated that in situ changes in protein conformation can be monitored in their physiological environment. We show that GFP-Akt-YFP retains properties associated with Akt itself and can be exploited to report on conformational changes through altered FRET. We therefore conclude that Akt indeed undergoes a conformational change at the plasma membrane and suggest that this approach of monitoring in situ conformational changes can be utilized for other proteins, including related AGC kinase family members.
